One day a tear fluid workup could be as routine as bloodwork during a physical exam as well as in diagnosing a myriad of conditions, from dry eye disease to Alzheimer’s.
The new study provides some of the first evidence that synthetic compounds that activate sigma 1 receptor may one day help mitigate damage from glaucoma.